SCHEMBL17851237

SCHEMBL17851237

Cc1cccc2c1oc1c(-c3cccc4c3oc3ccccc34)cccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.55
PRKDC P78527 4/20 0.44
PIK3CD O00329 1/20 0.43
PIK3CB P42338 1/20 0.43
TTR P02766 1/20 0.40
MCL1 Q07820 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
GGPS1 O95749 1/20 0.39
ATM Q13315 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2C19 P33261 1/20 0.39
PGR P06401 1/20 0.39
TP53 P04637 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
AHR P35869 1/20 0.39
MAOA P21397 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16177374 0.91 ALOX5 (0.57) ALOX5PRKDCPIK3CDPIK3CBHDAC8
SCHEMBL12108 0.91 ALOX5 (0.46) ALOX5TTRMCL1MEN1KMT2A
SCHEMBL16477678 0.89 ALOX5 (0.55) ALOX5PRKDCPIK3CDPIK3CBHDAC8
SCHEMBL15785766 0.89 PGR (0.44) ALOX5TTRMCL1MEN1KMT2A
SCHEMBL19521824 0.89 ALOX5 (0.58) ALOX5PRKDCTTRGGPS1ATM
SCHEMBL5028273 0.89 ALOX5 (0.66) ALOX5PRKDCPIK3CDPIK3CBHDAC8
SCHEMBL12799811 0.89 MCL1 (0.47) ALOX5PRKDCMCL1MAOAALDH1A1
SCHEMBL18179417 0.88 ALOX5 (0.51) ALOX5PRKDCPIK3CDPIK3CBHDAC8
SCHEMBL16185335 0.87 NPC1 (0.44) ALOX5PRKDCMCL1RXFP1MAOA
SCHEMBL10945864 0.87 ALOX5 (0.68) ALOX5PRKDCPIK3CDPIK3CBHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640252-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS UDC Ireland Limited (IE) 2020-04-22 EP disclosed
US-10431750-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2019-10-01 US disclosed
US-20190273211-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications UDC IRELAND LTD (IE) 2019-09-05 US disclosed
US-9806270-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2017-10-31 US disclosed
EP-3034508-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2016-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10431750-B2 4H-imidazo[1,2-a]imidazoles for electronic applications EIF4A1, ITPR2, ITPR1 ALOX5 4573/4885PRKDC 2909/4885PIK3CD 318/4885
US-20190273211-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications PAH, NISCH, KCNH1 ALOX5 4765/4885PRKDC 3618/4885PIK3CD 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.